Antibody, not Cellular, Immune Responses to SARS-CoV-2 Vaccination Outperform Infection in Inflammatory Bowel Disease Patients.

González Cueto E., Edmans M., Wellens J., Cadwell K., Thompson C., Satsangi J., Wong S-Y., ICARUS-IBD working group None.

DOI

10.1093/ibd/izad265

Type

Journal article

Journal

Inflamm Bowel Dis

Publication Date

02/05/2024

Volume

30

Pages

859 - 862

Keywords

SARS-CoV-2, biological therapy, immune response, inflammatory bowel disease, Humans, COVID-19, Inflammatory Bowel Diseases, SARS-CoV-2, COVID-19 Vaccines, Antibodies, Viral, Immunity, Cellular, Female, Male, Adult, Vaccination, Middle Aged

Permalink Original publication